Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.


TSXV:RHT - Post by User

Comment by mjh9413on Jun 16, 2023 3:44pm
107 Views
Post# 35500845

RE:calculation on CEO salary and value of share buy back

RE:calculation on CEO salary and value of share buy backI've said this before. Look at ALL those payments to related parties, mainly Crossley and her co-director> Fees for acconting to latter maybe be warranted but any CEO does not deserve $1/4MM or more for such capital destrucion over many more than 4 years.  And all those options to insiders and consultants, when latter might also be insiders...yet no expected option numbers on SEDI.
I'm not in RHT anymore but like to see what is being said. I'd possibly come back in when I see them age their receivables and the numbers look sound.
<< Previous
Bullboard Posts
Next >>